← Back to Screener
Agape ATP Corporation Common Stock (ATPC)
Price$2.52
Favorite Metrics
Price vs S&P 500 (26W)-102.79%
Price vs S&P 500 (4W)13.02%
Market Capitalization$2.52M
All Metrics
Book Value / Share (Quarterly)$22.83
P/TBV (Annual)2.45x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)9.05%
Cash Flow / Share (Quarterly)$-2.85
Price vs S&P 500 (YTD)-56.83%
Gross Margin (TTM)52.68%
Net Profit Margin (TTM)-182.59%
EPS (TTM)$-5.04
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$-5.04
Revenue Growth (5Y)-3.12%
EPS (Annual)$-31.74
ROI (Annual)-119.35%
Gross Margin (Annual)57.39%
Net Profit Margin (5Y Avg)-132.29%
Cash / Share (Quarterly)$0.13
Revenue Growth QoQ (YoY)11.86%
ROA (Last FY)-76.25%
Revenue Growth TTM (YoY)9.67%
EBITD / Share (TTM)$-1.82
ROE (5Y Avg)-71.18%
Operating Margin (TTM)-189.02%
Cash Flow / Share (Annual)$-34.80
P/B Ratio0.11x
P/B Ratio (Quarterly)2.77x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.69x
Net Interest Coverage (TTM)-26.83x
ROA (TTM)-13.99%
EPS Incl Extra (Annual)$-31.74
Current Ratio (Annual)2.48x
Quick Ratio (Quarterly)15.67x
3-Month Avg Trading Volume1.89M
52-Week Price Return-97.30%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$22.82
P/S Ratio (Annual)1.91x
Asset Turnover (Annual)0.41x
52-Week High$128.25
Operating Margin (5Y Avg)-122.76%
EPS Excl Extra (Annual)$-31.74
26-Week Price Return-95.90%
Quick Ratio (Annual)1.93x
13-Week Price Return-53.76%
Total Debt / Equity (Annual)0.07x
Current Ratio (Quarterly)16.21x
Enterprise Value$2.516
Revenue / Share Growth (5Y)429.05%
Asset Turnover (TTM)0.08x
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)11.96x
Pretax Margin (Annual)-187.57%
Cash / Share (Annual)$25.57
3-Month Return Std Dev284.70%
Gross Margin (5Y Avg)67.02%
Net Income / Employee (TTM)$-0
ROE (Last FY)-127.81%
Net Interest Coverage (Annual)-5.40x
EPS Basic Excl Extra (Annual)$-31.74
P/FCF (TTM)11.46x
Receivables Turnover (TTM)60.14x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-5.04
Receivables Turnover (Annual)63.99x
ROI (TTM)-14.90%
P/S Ratio (TTM)1.70x
Pretax Margin (5Y Avg)-128.76%
Revenue / Share (Annual)$16.99
Tangible BV / Share (Annual)$24.06
Price vs S&P 500 (52W)-131.94%
Year-to-Date Return-52.90%
5-Day Price Return-7.01%
EPS Normalized (Annual)$-31.74
ROA (5Y Avg)-44.39%
Net Profit Margin (Annual)-186.77%
Month-to-Date Return-4.18%
Cash Flow / Share (TTM)$-0.02
EBITD / Share (Annual)$-32.01
Operating Margin (Annual)-194.54%
ROI (5Y Avg)-69.31%
EPS Basic Excl Extra (TTM)$-5.04
P/TBV (Quarterly)2.77x
P/B Ratio (Annual)2.44x
Inventory Turnover (TTM)13.99x
Pretax Margin (TTM)-186.26%
Book Value / Share (Annual)$24.23
Price vs S&P 500 (13W)-56.14%
Beta-0.02x
Revenue / Share (TTM)$1.48
ROE (TTM)-15.01%
52-Week Low$1.72
Industry Peers — Health Services(13)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
ATPCAgape ATP Corporation Common Stock | — | 9.67% | -189.02% | -15.01% | $2.52 |
PRVAPrivia Health Group, Inc. Common Stock | 131.66x | 22.26% | 1.61% | 3.29% | $24.08 |
LFSTLifeStance Health Group, Inc. Common Stock | 277.93x | -12.76% | 2.07% | 0.65% | $6.92 |
WGSGeneDx Holdings Corp. Class A Common Stock | — | 39.97% | -3.06% | -7.41% | $69.71 |
USPHUS Physical Therapy Inc | 28.66x | 16.33% | 11.08% | 8.00% | $75.72 |
INNVInnovAge Holding Corp. Common Stock | — | 13.48% | 1.01% | 2.66% | $7.95 |
PNTGThe Pennant Group, Inc. Common Stock | 36.33x | 36.31% | 5.47% | 9.31% | $29.64 |
TALKTalkspace, Inc. Common Stock | 111.06x | 22.00% | 1.38% | 6.89% | $5.18 |
OMDAOmada Health, Inc. Common Stock | — | — | -5.41% | -7.10% | $14.04 |
SRTAStrata Critical Medical, Inc. Class A Common Stock | 9.61x | -3.02% | -10.18% | 16.45% | $4.52 |
DCGODocGo Inc. Common Stock | 3.28x | -47.74% | -56.81% | -71.45% | $0.68 |
About
Agape ATP Corp develops and sells nutritional supplements and skincare products designed to support cellular health, detoxification, and anti-aging. The company operates through two segments: its core skin care and wellness business, which provides health products and advisory services and generates the majority of revenue, and a green energy division offering renewable energy solutions. The company targets health-conscious consumers through its diversified product portfolio and wellness advisory services.